Abstract Coronavirus disease 2019 (COVID-19) has affected more than 6 million patients
worldwide. Deep venous thrombosis (DVT) has been increasingly recognized complication …

Deep venous thrombosis (DVT) is a severe complication of coronavirus disease 2019
(COVID-19). The purpose of this study was to study the prevalence, risk factors …

Background Studies have shown that COVID-19 could lead coagulation defects, resulting in
increased morbidity and mortality. In this study, we sought to estimate the prevalence of …

Background Deep vein thrombosis (DVT) has been reported to occur at different rates in
patients with coronavirus disease 2019 (COVID-19). Limited data exist regarding …

Deep vein thrombosis (DVT) is prevalent in patients with coronavirus disease 2019 (COVID-
19). However, the risk factors and incidence rate of DVT remains elusive. Here, we aimed to …

Background COVID-19 appears to be associated with a high risk of venous
thromboembolism (VTE). We aimed to systematically review and meta-analyze the risk of …

Objective We investigated the incidence, risk factors, clinical characteristics and outcomes of
DVT in patients with COVID-19 attending the ED before hospitalization. Methods We …

Objectives Coronavirus disease 2019 (COVID-19) can lead to systemic coagulation
activation and thrombotic complications including venous thromboembolism. This study …

Background: Accumulating evidence suggests that coronavirus disease 2019 (COVID-19) is
associated with hypercoagulative status, particularly for critically ill patients in the intensive …

Objective Early reports suggest that patients with novel coronavirus disease-2019 (COVID-
19) infection carry a significant risk of altered coagulation with an increased risk for venous …